U.S. Markets closed

Sio Gene Therapies, Inc. (SIOX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.8600-0.0300 (-1.04%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.65
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.1500
52 Week Low 31.9000
50-Day Moving Average 32.7835
200-Day Moving Average 32.7340

Share Statistics

Avg Vol (3 month) 32.41M
Avg Vol (10 day) 3919.54k
Shares Outstanding 548.47M
Float 26.52M
% Held by Insiders 138.58%
% Held by Institutions 125.00%
Shares Short (Dec 30, 2020) 41.34M
Short Ratio (Dec 30, 2020) 40.36
Short % of Float (Dec 30, 2020) 44.50%
Short % of Shares Outstanding (Dec 30, 2020) 42.76%
Shares Short (prior month Nov 29, 2020) 41.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2020
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-39.39%
Return on Equity (ttm)-113.63%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-49.27M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)63.17M
Total Cash Per Share (mrq)1.3
Total Debt (mrq)89k
Total Debt/Equity (mrq)0.13
Current Ratio (mrq)7.00
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-56.32M
Levered Free Cash Flow (ttm)-35.24M